Stockreport

Imunon Inc (IMNN) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial Management [Yahoo! Finance]

Imunon, Inc.  (IMNN) 
PDF Research and Development Expenses: $7.8 million for 2025, significantly lower than 2024. General and Administrative Expenses: Down 8% year-over-year. Net Loss: $14. [Read more]